| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
*
Immunology Section, Department of Cell and Molecular Biology, Lund University, Lund, Sweden; and
Gwen Knapp Center for Lupus and Immunology Research, Committee on Immunology and Department of Pathology, University of Chicago, Chicago, IL 60637
The majority of T lymphocytes carrying the NK cell marker NK1.1
(NKT cells) depend on the CD1d molecule for their development and are
distinguished by their potent capacity to rapidly secrete cytokines
upon activation. A substantial fraction of NKT cells express a
restricted TCR repertiore using an invariant TCR V
14-J281
rearrangement and a limited set of TCR Vß segments, implying
recognition of a limited set of CD1d-associated ligands. A second group
of CD1d-reactive T cells use diverse TCR potentially recognizing a
larger diversity of ligands presented on CD1d. In TCR-transgenic mice
carrying rearranged TCR genes from a CD1d-reactive T cell with the
diverse type receptor (using V3.2/Vß9 rearrangements), the
majority of T cells expressing the transgenic TCR had the typical
phenotype of NKT cells. They expressed NK1.1, CD122, intermediate TCR
levels, and markers indicating previous activation and were CD4/CD8
double negative or CD4+. Upon activation in vitro, the
cells secreted large amounts of IL-4 and IFN-
, a characteristic of
NKT cells. In mice lacking CD1d, TCR-transgenic cells with the NKT
phenotype were absent. This demonstrates that a CD1d-reactive TCR of
the "non-V 14" diverse type can, in a ligand-dependent way,
direct development of NK1.1+ T cells expressing expected
functional and cell-surface phenotype
characteristics.
This article has been cited by other articles:
|
|
 |
|
  M. I. Zimmer, H. P. Nguyen, B. Wang, H. Xu, A. Colmone, K. Felio, H.-J. Choi, P. Zhou, M.-L. Alegre, and C.-R. Wang Polymorphisms in CD1d affect antigen presentation and the activation of CD1d-restricted T cells PNAS, February 10, 2009; 106(6): 1909 - 1914. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Cosmi, R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor J. Exp. Med., August 4, 2008; 205(8): 1903 - 1916. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Rogers, S. Burchat, J. Gage, M. Hasu, M. Thabet, L. Wilcox, T. A. Ramsamy, and S. C. Whitman Deficiency of invariant V{alpha}14 natural killer T cells decreases atherosclerosis in LDL receptor null mice Cardiovasc Res, April 1, 2008; 78(1): 167 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Ambrosino, M. Terabe, R. C. Halder, J. Peng, S. Takaku, S. Miyake, T. Yamamura, V. Kumar, and J. A. Berzofsky Cross-Regulation between Type I and Type II NKT Cells in Regulating Tumor Immunity: A New Immunoregulatory Axis J. Immunol., October 15, 2007; 179(8): 5126 - 5136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Wakao, H. Kawamoto, S. Sakata, K. Inoue, A. Ogura, R. Wakao, A. Oda, and H. Fujita A Novel Mouse Model for Invariant NKT Cell Study J. Immunol., September 15, 2007; 179(6): 3888 - 3895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Vincent, X. Xiong, E. P. Grant, W. Peng, and M. B. Brenner CD1a-, b-, and c-Restricted TCRs Recognize Both Self and Foreign Antigens J. Immunol., November 15, 2005; 175(10): 6344 - 6351. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y.-T. Chen and J. T. Kung CD1d-Independent Developmental Acquisition of Prompt IL-4 Gene Inducibility in Thymus CD161(NK1)-CD44lowCD4+CD8- T Cells Is Associated with Complementarity Determining Region 3-Diverse and Biased V{beta}2/V{beta}7/V{beta}8/V{alpha}3.2 T Cell Receptor Usage J. Immunol., November 15, 2005; 175(10): 6537 - 6550. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Kent, Y. Chen, S. M. Clemmings, V. Viglietta, N. S. Kenyon, C. Ricordi, B. Hering, and D. A. Hafler Loss of IL-4 Secretion from Human Type 1a Diabetic Pancreatic Draining Lymph Node NKT Cells J. Immunol., October 1, 2005; 175(7): 4458 - 4464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Duarte, M. Stenstrom, S. Campino, M.-L. Bergman, M. Lundholm, D. Holmberg, and S. L. Cardell Prevention of Diabetes in Nonobese Diabetic Mice Mediated by CD1d-Restricted Nonclassical NKT Cells J. Immunol., September 1, 2004; 173(5): 3112 - 3118. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Mayerova and K. A. Hogquist Central Tolerance to Self-Antigen Expressed by Cortical Epithelial Cells J. Immunol., January 15, 2004; 172(2): 851 - 856. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Yoshimoto, B. Min, T. Sugimoto, N. Hayashi, Y. Ishikawa, Y. Sasaki, H. Hata, K. Takeda, K. Okumura, L. Van Kaer, et al. Nonredundant Roles for CD1d-restricted Natural Killer T Cells and Conventional CD4+ T Cells in the Induction of Immunoglobulin E Antibodies in Response to Interleukin 18 Treatment of Mice J. Exp. Med., April 21, 2003; 197(8): 997 - 1005. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Capone, D. Cantarella, J. Schumann, O. V. Naidenko, C. Garavaglia, F. Beermann, M. Kronenberg, P. Dellabona, H. R. MacDonald, and G. Casorati Human Invariant V{alpha}24-J{alpha}Q TCR Supports the Development of CD1d-Dependent NK1.1+ and NK1.1- T Cells in Transgenic Mice J. Immunol., March 1, 2003; 170(5): 2390 - 2398. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-H. Park, A. Weiss, K. Benlagha, T. Kyin, L. Teyton, and A. Bendelac The Mouse CD1d-restricted Repertoire Is Dominated by a Few Autoreactive T Cell Receptor Families J. Exp. Med., April 9, 2001; 193(8): 893 - 904. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
